Abstract:The Covid-19 pandemic has affected the global population since 2019. The rapid development and approval of vaccines has brought relief. Yet, effective cures are still being researched. Even if the pandemic situation may end, SARS-CoV-2 will remain and, thus, continued application of the drugs will lead to emissions of the active ingredients into the aquatic environment, as with other anthropogenic micropollutants. However, a general method for trace analysis of antiviral drugs is still missing. To this purpose, favipiravir, remdesivir, its active metabolite GS-441524, molnupiravir and its active metabolite EIDD-1931 were selected as representative analytes. A method was developed based on solid phase extraction and high-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight high-resolution mass spectrometry. Optimization comprised the choice of chromatographic columns, elution gradient, mass spectrometry and tandem mass spectrometry parameters. Solid phase extraction proved suitable for increase in limits of detection and quantitation. amelioration of the limits of detection and quantitation. Matrix effects were investigated applying the optimized method to a wastewater sample with added virustatics. All five compounds could be separated with reversed phase chromatography, whereas EIDD-1931 profited from hydrophilic interaction liquid chromatography. The optimized method yielded limits of detection and quantification of 2.1·10-1, 6.9·10-1 µg·L-1 for favipiravir, 1.8·10-3, 5.5·10-3 µg·L-1 for remdesivir, 1.9·10-3, 7.6·10-3 µg·L-1 for GS-441524, 2.9·10-3, 8.7·10-3 µg·L-1 for molnupiravir, and 1.3·10-1, 3.8·10-1 µg·L-1 for EIDD 1931. The method was first applied to compound stability testing at pH 2.8 and 9.7. At pH 2.8, remdesivir, GS-441524 and molnupiravir proved stable, whereas about 14% of EIDD-1931 and favipiravir were degraded. All five antiviral compounds were almost completely decomposed at pH 9.7. The application of the method was further demonstrated for potential transformation product detection on favipiravir ozonation monitoring.

Identification of transformation products of antiviral drugs formed during biological wastewater treatment and their occurrence in the urban water cycle

Discovering transformation products of pharmaceuticals in domestic wastewaters and receiving rivers by using non-target screening and machine learning approaches

Occurrence, removal and mass loads of antiviral drugs in seven wastewater treatment plants with various treatment processes

Uncovering transformation products of four organic contaminants of concern by photodegradation experiments and analysis of real samples from a local river

Chlorination of antiviral drug ribavirin: Kinetics, nontargeted identification, and concomitant toxicity evolution

AOP-Based Transformation of Abacavir in Different Environments: Evolution Profile of Descyclopropyl-Abacavir and In Silico Toxicity Assessment of the Main Transformation Products

A sustainable approach for the removal methods and analytical determination methods of antiviral drugs from water/wastewater: A review

Occurrence and Removal of Antibiotics and the Corresponding Resistance Genes in Wastewater Treatment Plants: Effluents’ Influence to Downstream Water Environment

Antiviral drugs in wastewater are on the rise as emerging contaminants: A comprehensive review of spatiotemporal characteristics, removal technologies and environmental risks

Stability and WBE biomarkers possibility of 17 antiviral drugs in sewage and gravity sewers

Suspect and Nontarget Screening Reveal the Underestimated Risks of Antibiotic Transformation Products in Wastewater Treatment Plant Effluents.

Degradation of selected pharmaceuticals detected in wastewater systems using an enzyme-mediator system and identification of resulting transformation products

Transformation products of antibacterial drugs in environmental water: Identification approaches based on liquid chromatography-high resolution mass spectrometry

Nontarget Discovery of Antimicrobial Transformation Products in Wastewater Based on Molecular Networks

Transformation products of tetracyclines in three typical municipal wastewater treatment plants

Hydrolytic Transformation Mechanism of Tetracycline Antibiotics: Reaction Kinetics, Products Identification and Determination in WWTPs.

Indirect Photochemical Transformations of Acyclovir and Penciclovir in Aquatic Environments Increase Ecological Risk

Determination of anti-SARS-CoV-2 virustatic pharmaceuticals in the aquatic environment using high-performance liquid chromatography high-resolution mass spectrometry

Can Environmental Pharmaceuticals Be Photocatalytically Degraded and Completely Mineralized in Water Using G-C3n4/tio2 under Visible Light Irradiation?—implications of Persistent Toxic Intermediates

Retrospective mass spectrometric analysis of wastewater-fed mesocosms to assess the degradation of drugs and their human metabolites

Revealing Specific Transformation Pattern of Sulfonamides During Wastewater Biological Treatment Processes by Molecular Networking Nontarget Screening